Substituted imidazoquinoxalines

US8729082B2 · kind B2 · utility

Assignee

• Bayer Intellectual Property GmbH · DE

Inventors

• Marcus Koppitz · Berlin, DE
• Benjamin Bader · Berlin, DE
• Ulf Bömer · Glienicke, DE
• Bertolt Kreft · Kleinmachnow, DE
• Philip Lienau · Berlin, DE
• Tobias Marquardt · Wuppertal, DE
• Stefan Prechtl · Berlin, DE
• Gerhard Siemeister · Berlin, DE
• Christof Wegscheid-Gerlach · Marburg, DE

Key dates

• Filing date: Apr 24, 2010
• Grant date: May 20, 2014
• Expiry date: Apr 24, 2030

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to substituted imidazoquinoxaline compounds of general formula (I) as inhibitors of Mps-1 Kinase or TTK, and being active against inflammation and cancer.